Luminar Media Group Inc., and The Jenex Corporation Terminate Exclusive License Agreement
September 29, 2017 16:18 ET
|
Luminar Media Group, Inc.
Toronto, Ontario, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR) is announcing that The Jenex Corporation (TSXV: JEN.H) ("Jenex”) has terminated the license...
Luminar Media Group Inc.: Issues Statement About Promotional Activity Concerning Its Common Stock
April 27, 2017 08:57 ET
|
Luminar Media Group, Inc.
Toronto, Ontario, April 27, 2017 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR) today announced that it has been made aware of recent promotional activity concerning LRGR...
Luminar Media Group Inc.: Testing to Begin on TherOZap™ Working Prototype & Topical Cannabidiol Oil against the Zika and West Nile Viruses
April 18, 2017 11:39 ET
|
Luminar Media Group, Inc.
Toronto, Ontario, April 18, 2017 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR) and The Jenex Corporation (Jenex, NEX: JEN.H) report that testing of a topical cannabidiol...
Luminar Media Group Inc.: University Heath Network to initiate testing of TherOZap™ against the Zika and West Nile Viruses
April 07, 2017 09:20 ET
|
Luminar Media Group, Inc.
Toronto, Ontario, April 07, 2017 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR) and The Jenex Corporation (Jenex, NEX: JEN.H) report the completion of a working prototype...
Luminar Media Group Inc., Provides Update on TherOZap™ Working Prototype
March 06, 2017 08:30 ET
|
Luminar Media Group, Inc.
Toronto, Ontario, March 06, 2017 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), reports that the development of the working prototype for the patent pending TherOZap™ is...
Luminar Media Group Inc., Provides Update on Next Generation Technology, Jenex to Test TherOZap™ Against the West Nile Virus & Zika Virus
January 24, 2017 08:30 ET
|
Luminar Media Group, Inc.
Toronto, Ontario, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), reports that development of the working prototype for TherOZap™ is progressing well and...
Luminar Media Group Inc., announces testing of TherOZap™ Technology against the Zika Virus and West Nile Virus
December 08, 2016 09:15 ET
|
Luminar Media Group, Inc.
Miami, Florida, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), reports the TherOZap™ technology being developed by its licensing partner, The Jenex...
Luminar Media Group Inc. Introduces TherOZap™, - the Next Generation Thermal Therapy Insect Device
November 22, 2016 08:30 ET
|
Luminar Media Group, Inc.
Miami, Florida, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), through a licensing partnership with The Jenex Corporation (Jenex, NEX: JEN.H) will market,...
Luminar Media Group Inc. Signs Exclusive License Agreement for USD $250,000 with Jenex For Next Generation Thermal Therapy Insect Device
November 04, 2016 10:58 ET
|
Luminar Media Group, Inc.
Miami, Florida , Nov. 04, 2016 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc. (Luminar, OTCMKTS: LRGR) and The Jenex Corporation (Jenex, NEX: JEN.H) are pleased to announce that the two...